154 related articles for article (PubMed ID: 11160641)
1. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
3. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
4. Role of Cyp1A1 in modulation of antitumor properties of the novel agent 2-(4-amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in human breast cancer cells.
Chua MS; Kashiyama E; Bradshaw TD; Stinson SF; Brantley E; Sausville EA; Stevens MF
Cancer Res; 2000 Sep; 60(18):5196-203. PubMed ID: 11016648
[TBL] [Abstract][Full Text] [Related]
5. Catalytic properties of polymorphic human cytochrome P450 1B1 variants.
Shimada T; Watanabe J; Kawajiri K; Sutter TR; Guengerich FP; Gillam EM; Inoue K
Carcinogenesis; 1999 Aug; 20(8):1607-13. PubMed ID: 10426814
[TBL] [Abstract][Full Text] [Related]
6. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
[TBL] [Abstract][Full Text] [Related]
7. Oxidative metabolism of the alkaloid rutaecarpine by human cytochrome P450.
Ueng YF; Don MJ; Jan WC; Wang SY; Ho LK; Chen CF
Drug Metab Dispos; 2006 May; 34(5):821-7. PubMed ID: 16501007
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of melatonin by human cytochromes p450.
Ma X; Idle JR; Krausz KW; Gonzalez FJ
Drug Metab Dispos; 2005 Apr; 33(4):489-94. PubMed ID: 15616152
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.
McFadyen MC; McLeod HL; Jackson FC; Melvin WT; Doehmer J; Murray GI
Biochem Pharmacol; 2001 Jul; 62(2):207-12. PubMed ID: 11389879
[TBL] [Abstract][Full Text] [Related]
11. Involvement of human liver cytochrome P450 3A in vinblastine metabolism: drug interactions.
Zhou-Pan XR; Sérée E; Zhou XJ; Placidi M; Maurel P; Barra Y; Rahmani R
Cancer Res; 1993 Nov; 53(21):5121-6. PubMed ID: 8221648
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel (Taxotere) is not metabolized by recombinant human CYP1B1 in vitro, but acts as an effector of this isozyme.
Bournique B; Lemarié A
Drug Metab Dispos; 2002 Nov; 30(11):1149-52. PubMed ID: 12386117
[TBL] [Abstract][Full Text] [Related]
13. Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1.
Chang TK; Lee WB; Ko HH
Can J Physiol Pharmacol; 2000 Nov; 78(11):874-81. PubMed ID: 11100935
[TBL] [Abstract][Full Text] [Related]
14. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells.
Androutsopoulos VP; Ruparelia K; Arroo RR; Tsatsakis AM; Spandidos DA
Toxicology; 2009 Oct; 264(3):162-70. PubMed ID: 19666078
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes.
Piver B; Fer M; Vitrac X; Merillon JM; Dreano Y; Berthou F; Lucas D
Biochem Pharmacol; 2004 Aug; 68(4):773-82. PubMed ID: 15276085
[TBL] [Abstract][Full Text] [Related]
16. In vitro biotransformation of imatinib by the tumor expressed CYP1A1 and CYP1B1.
Rochat B; Zoete V; Grosdidier A; von Grünigen S; Marull M; Michielin O
Biopharm Drug Dispos; 2008 Mar; 29(2):103-18. PubMed ID: 18188833
[TBL] [Abstract][Full Text] [Related]
17. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
Zhou S; Paxton JW; Tingle MD; Kestell P
Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover).
Roberts DW; Doerge DR; Churchwell MI; Gamboa da Costa G; Marques MM; Tolleson WH
J Agric Food Chem; 2004 Oct; 52(21):6623-32. PubMed ID: 15479032
[TBL] [Abstract][Full Text] [Related]
19. A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis.
Chun YJ; Kim S; Kim D; Lee SK; Guengerich FP
Cancer Res; 2001 Nov; 61(22):8164-70. PubMed ID: 11719446
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of taxoids by human cytochromes P450: structure-activity relationship.
Monsarrat B; Royer I; Wright M; Cresteil T
Bull Cancer; 1997 Feb; 84(2):125-33. PubMed ID: 9180834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
